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In the presence of ornithine and arginine, ornithine
carbamoyltransferase (OTCase) and arginase form a
one-to-one enzyme complex in which the activity of
OTCase is inhibited whereas arginase remains catalyti-
cally active. The mechanism by which these nonallo-
steric enzymes form a stable complex triggered by the
binding of their respective substrates raises the ques-
tion of how such a cooperative association is induced.
Analyses of mutations in both enzymes identify residues
that are required for their association, some of them
being important for catalysis. In arginase, two cysteines
at the C terminus of the protein are crucial for its epi-
arginase function but not for its catalytic activity and
trimeric structure. In OTCase, mutations of putative or-
nithine binding residues, Asp-182, Asn-184, Asn-185, Cys-
289, and Glu-256 greatly reduced the affinity for orni-
thine and impaired the interaction with arginase. The
four lysine residues located in the SMG loop, Lys-260,
Lys-263, Lys-265, and Lys-268, also play an important
role in mediating the sensitivity of OTCase to ornithine
and to arginase and appear to be involved in transduc-
ing and enhancing the signal given by ornithine for the
closure of the catalytic domain.
In Saccharomyces cerevisiae, the expression of arginine an-
abolic and catabolic genes is regulated at multiple levels in
response to a wide variety of metabolic signals such as arginine
and amino acid concentrations, nitrogen quality, and availabil-
ity (reviewed in Ref. 1). In addition, two mechanisms are
known to operate at the level of enzyme activity. Excess argi-
nine causes feedback inhibition of the activity of the two first
enzymes of the anabolic pathway, acetylglutamate synthase
and acetylglutamate kinase (2, 3). Another regulation known
as the “epiarginase control” leads to the inhibition of the activ-
ity of the anabolic ornithine carbamoyltransferase (OTCase)1
(EC 2.1.3.3) by the catabolic enzyme, arginase (EC 3.5.3.1). In
the presence of ornithine and arginine, the respective sub-
strates of the two enzymes (4), OTCase and arginase form a
one-to-one enzyme complex in which the activity of OTCase is
inhibited, whereas arginase remains catalytically active (5).
The epiarginase regulation prevents the recycling by OTCase
of ornithine produced by arginase and, because both enzymes
are cytosolic in S. cerevisiae, is expected to avoid the operation
of a futile urea cycle when yeast is growing on arginine as a
nitrogen source (4). This control was found in yeast species
showing a strong Pasteur effect and taxonomically related to
Saccharomyces (6) and was also reported in Bacillus subtilis
(7). The absence of the epiarginasic regulation in some species
can be linked to a mitochondrial localization of OTCase,
whereas arginase is cytosolic, as for example in Debaryomyces
hansenii, Hansenula anomala, and Schizosaccharomyces pombe
(8).
Direct interaction between OTCase and arginase, which are
trimeric, was demonstrated by molecular sieving, a complex
containing both enzymes being only observed in the presence of
ornithine and arginine (4). Purification in the presence of these
effectors (4) and equilibrium sedimentation and electron mi-
croscopy (9) identified an OTCase-arginase hexamer. The as-
sociation of the two enzymes was rapidly reversible in vivo as
well as in vitro under specific conditions, such as protein dilu-
tion, suggesting that no enzymatic modification was involved in
this inhibitory mechanism (4, 10, 11). It was proposed that the
ornithine regulatory receptor site on OTCase is distinct from
the catalytic site, because by mutation, heating, or chemical
alteration inhibition by arginase can be lost without impairing
the catalytic activity of OTCase (5). However, the occurrence of
a second ornithine binding site was not supported by the data
of Hensley and co-workers (9) who proposed that the binding of
ornithine to the active site promotes a conformational change
needed for the complex formation with arginase.
Vissers et al. (6) have investigated the occurrence of the
epiarginase control in 32 yeast species belonging to 12 different
genera and obtained some correlation between the sensitivity
of OTCases to excess ornithine and their sensitivity to argin-
ase. Indeed, all OTCases inhibited by arginase present a
marked inhibition by excess ornithine. However, the reverse is
not true, and some arginase insensitive OTCases are inhibited
by excess ornithine. To get deeper insight at the molecular level
into the mechanism involved in the inhibition of OTCase by
arginase, we created and analyzed in the S. cerevisiae OTCase
a series of mutations leading to the loss of inhibition of its
activity by arginase. We also identified residues in the arginase
that are required for its regulatory function.
EXPERIMENTAL PROCEDURES
Strains and Media
S. cerevisiae HY is a diploid strain obtained by crossing strains HF7c
(MATa, ura3–52, his3–200, lys2–801, ade2–101, trp1–901, leu2–3,112,
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number 98/03-231 between the French Community of Belgium and the
Free University of Brussels (U. L. B.) and by the Fonds National de la
Recherche Scientifique. The costs of publication of this article were
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gal4–542, gal80–538, LYS2::GAL1-HIS3, URA3::(GAL4(17-mer)3-CYC1-
lacZ) and Y187 (MAT, ura3–52, his3–200, ade2–101, trp1–901, leu2–
3,112, met, gal4, gal80, URA3::GAL1-lacZ) (12) and was the recip-
ient strain for experiments using the two-hybrid system. The yeast
strain MaV99 (MATa, SPAL10::URA3), which contains an integrated
GAL1-URA3 reporter gene activated by the GAL upstream activation
sequence and derives from the strain MaV52 (MATa, ura3–52, leu2–
3,112, trp1–901, his3–200, ade2–101, gal4, gal80, can1R, cyh2R,
GAL1::HIS3@LYS2, GAL1::lacZ) (13), was the recipient strain for ex-
periments using the reverse two-hybrid system. This strain lacks both
GAL4 and GAL80 genes and contains integrated GAL1-lacZ and GAL1-
HIS3 reporter genes. The yeast strain 02859d (ura3, leu2, trp1), iso-
genic to the wild type strain 1278b, was used to delete the CAR1 and
ARG3 genes. Deletion of the CAR1 gene was achieved by transformat-
ing the strain 02859d with pWX4 plasmid as described by Dubois and
Messenguy (14), leading to strain 02859dcar1. Deletion of the ARG3
gene was performed using the PCR strategy developed by Wach (15).
The disruption cassette, containing the kanMX4 cassette with long
flanking regions homologous to the ARG3 gene, was synthesized using
PCR. This cassette confers to yeast a resistance to Geneticin (G418).
The homologous regions of ARG3 gene were located upstream from the
start codon and downstream from the stop codon. The PCR protocols for
preparation of this cassette were identical to those described in Wach
(15). Integration of the kanMX4 cassette at the target locus was con-
firmed using the PCR strategy as described by Wach (15). Strain
02859darg3-car1 (ura3, leu2, trp1, arg3::kanMX4, car1) was used as
recipient strain for transformation with plasmids overexpressing CAR1
or ARG3 genes. Strain 12S16c (ura3, leu2, arg3) (a gift from M.
Crabeel) was used as recipient strain for transformation with plasmids
expressing wild type or mutated ARG3 genes or with plasmids expressing
GBD-OTCase or GAD-OTCase. Strain 12T7cI (ura3, car1) (14), isogenic
to the wild type strain 1278b, was used as recipient strain for transfor-
mation with plasmids expressing GBD-arginase or GAD-arginase.
The strains used in the two-hybrid analysis were grown on synthetic
medium containing 0.7% yeast nitrogen base without amino acids. This
medium was supplemented with 2% glucose and all amino acids except
those whose omission was required for plasmid selection. All the other
strains were grown on minimal medium (M.am) containing 10 mM
(NH4)2SO4, 3% glucose or 2% galactose, vitamins, and mineral traces as
described previously (16). The lithium acetate procedure was used to
transform the recipient yeast strains (17) Escherichia coli strains XL1-
Blue, XL1-Red, and HB101 from Stratagene were used for plasmid
amplification, plasmid mutagenesis, and selection of plasmids contain-
ing a functional LEU2 gene and the GAD-ARG3 gene, respectively.
Construction of Plasmids Overexpressing OTCase and
Arginase under the GAL10 Promoter
To overexpress OTCase and arginase, we amplified by PCR the
full-length ARG3 and CAR1 genes, using as template the genomic DNA
from the wild type strain 1278b and as primers the appropriate
oligonucleotides extended with BamHI restriction sites. These frag-
ments were inserted in the BamHI site of vector pYeF2 (pUC19, 2,
URA3, GAL10 promoter) (18), yielding plasmids pDC2 (pGAL10-ARG3,
2, URA3) and pEJ24 (pGAL10-CAR1, 2, URA3). The two genes were
sequenced to ensure that no mutation was introduced during the
PCR procedure.
Construction of DNA-binding Domain and
Activation Domain Fusions
The DNA binding domain of the Gal4 activator, Gal4-(1–147), is
referred to as GBD, and its activation domain, Gal4-(768–881), is
referred to as GAD. The underlined GBD and GAD refer to the DNA
sequences encoding these domains.
GBD-containing fusion genes were constructed in vector pAS2 (19).
Transformants harboring the vector, or a derivative thereof, were se-
lected by omitting tryptophan from the yeast nitrogen base medium
(Difco, Detroit, MI). GAD-containing fusion genes were constructed in
vector pACTII (19), transformants harboring the vector, or a derivative
thereof, were selected by omitting leucine from the yeast nitrogen base
medium.
GBD-ARG3 and GAD-ARG3 Fusions—To construct the GBD-ARG3
and GAD-ARG3 gene fusions, we PCR-amplified the ARG3 gene, using
as template the genomic DNA from the wild type 1278b strain and as
primers the appropriate oligonucleotides flanked by a BamHI site for
the 5-end and a XhoI site for the 3-end. This DNA fragment was
digested by BamHI and XhoI and inserted into the pAS2 vector, then
digested by BamHI and SalI, leading to plasmid pGBD-ARG3, and
inserted into the pACTII vector, and finally digested again by BamHI
and XhoI, leading to plasmid pGAD-ARG3. In these GBD-ARG3 and
GAD-ARG3 fusions, we determined the nucleotide sequence to ensure
that the fusions were in-frame and that no mutation had been intro-
duced during the PCR procedure.
GBD-CAR1 and GAD-CAR1 Fusions—To construct the GBD-CAR1
and GAD-CAR1 gene fusions, we amplified by PCR the CAR1 gene,
using as template the genomic DNA from the wild type 1278b strain
and as primers the appropriate oligonucleotides flanked by a BamHI
site for the 5-end and a XhoI site for the 3-end. This DNA fragment
was digested by BamHI and XhoI and inserted into the pAS2 vector,
then digested by BamHI and SalI, leading to plasmid pGBD-CAR1, and
inserted into the pACTII vector, then finally digested again by BamHI
and XhoI, leading to plasmid pGAD-CAR1. In these GBD-CAR1 and
GAD-CAR1 fusions, we determined the nucleotide sequence to ensure
that the fusions were in-frame and that no mutation had been intro-
duced during the PCR procedure.
Selection of Mutations in the ARG3 Gene by the
“Reverse Two-hybrid” Assay
Plasmid pGAD-ARG3 was used to transform E. coli strain XL1-Red
(Stratagene) to obtain mutations in the ARG3 gene, because this strain
is highly mutagenic. Plasmids containing the mutated GAD-arg3 gene
were extracted from a pool of bacterial transformants and used to
transform yeast strain MaV99 containing plasmid GBD-CAR1. This
strain is suitable for the use of the reverse two-hybrid assay, because it
contains the URA3 reporter gene under the control of the UASGAL
sequences. The URA3 gene allowed the selection of mutated GAD-
OTCases having lost their interaction with GBD-arginase, because only
the strains that did not express the URA3 gene could grow on a medium
containing 5-fluoroorotic acid plus 25 g of uracil. 15 candidates were
obtained, and their DNA was extracted and used to transform E. coli
strain HB101 (leu, pro, amps). This allowed the selection of plasmids
containing a functional LEU2 gene and the GAD-ARG3 gene, and
eliminated the pGBD-CAR1 plasmid.
Construction of Deletion and Point Mutations in the ARG3 Gene
The deletion of the region between amino acids 166 and 169
(EVNK) was created by in vitro mutagenesis on double-stranded DNA
from plasmid pKV0c2 (pBR322, 2, URA3, ARG3), which contains the
ARG3 gene, leading to plasmid parg3-M1. The substitutions T68G,
E123S, E123A, G181R, D182N, N184Q, N185Q, C191M/C194N/F197V,
E256Q, E256A, K260R, K260A, K263R, K263A, K265R, K265A, K268R,
K268A, C289S, L290S, L290Q, and Q294P were introduced in OTCase
by site-directed in vitro mutagenesis on plasmid pDC2 (pGAL10-ARG3,
2, URA3), leading to plasmids pME223 (T68G), pME204 (E123S),
pME206 (E123A), pME216 (G181R), pFV48 (D182N), pME234
(N184Q), pME235 (N185Q), pME211 (C191M/C194N/F197V), pME205
(E256Q), pME207 (E256A), pME217 (K260R), pME218 (K260A),
pME213 (K263R), pME208 (K263A), pME240 (K265R), pME219
(K265A), pME241 (K268R), pME220 (K268A), pME237 (C289S),
pME238 (L290S), pME239 (L290Q), and pME221 (Q294P), respec-
tively. All genes were sequenced to ensure that no additional mutation
had been introduced during the PCR procedure.
Construction of Deletion and Point Mutations in the CAR1 Gene
The deletion of the region between amino acids 78 and 86 (GGSS-
VMIDG) was generated by in vitro mutagenesis on double-stranded
DNA from plasmid pEJ24 (pGAL10-CAR1, 2, URA3), leading to plas-
mid pAM4. The substitutions H309K/H312E and C321R/C326T were
introduced in arginase by site-directed in vitro mutagenesis on plasmid
pEJ24 (pGAL10-CAR1, 2, URA3), leading to plasmids pME209
(H309K/H312E) and pME210 (C321R/C326T), respectively. The
changes of the amino acids H309K/H312E/C321R/C326T were gener-
ated in arginase by site-directed in vitro mutagenesis on plasmid
pME210, leading to plasmid pME222 (H309K/H312E/C321R/C326T).
All genes were sequenced to ensure that no additional mutation had
been introduced during the PCR procedure.
Enzyme Assays
-Galactosidase activity was assayed as described by Miller (20).
Protein contents were determined by the Folin method. Arginase activ-
ity was assayed as described previously (5). OTCase activity was deter-
mined by citrulline detection (21). Routinely the OTCase activities were
measured in the presence of 50 mM Tris-HCl buffer, pH 8.0, 5 mM
carbamoyl phosphate and at ornithine saturation. The reaction was
carried out at 30 °C for 30 min and was stopped by addition of HCl at a
Residues for OTCase-Arginase Interaction and Activity Control 21551
 at B
IB
LIO
TH
EQUE UNIV DE NAM
UR on M
ay 14, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
final concentration of 0.5 M. In the experiments of OTCase inhibition by
arginase, 1 mM agmatine, an arginine analog, and increasing amounts
of arginase (up to 1000 arginase units) were added in the incubation
mixture. This enzyme concentration corresponded to an amount of wild
type arginase 4-fold higher than the amount required for maximal
inhibition of OTCase. Agmatine was used in the OTCase-arginase bind-
ing assays instead of arginine to avoid arginine degradation at high
arginase concentration. The experiments shown in Fig. 5 (see below)
were performed using the more sensitive assay of Prescott and Jones
(22), for which standard curves for citrulline were generated in each
experiment. Specific activities were expressed in micromoles of citrul-
line formed per hour and per milligram of protein.
Modeling of Yeast OTCase
Alignment of OTCase amino acid sequences of S. cerevisiae,
S. pombe, human, Pyrococcus furiosus, E. coli, and Pseudomonas
aeruginosa has been performed with the ClustalW program (23, 24).
Based on this multiple sequence alignment, the structure of E. coli was
selected as template to construct a three-dimensional model of S. cer-
evisiae OTCase. Assignment of the coordinates, construction of addi-
tional loops (residues 45–50 and residues 160–169 in the yeast se-
quence), and minimization of the structure were carried out using the
Modeler4 program (25). The quality of the model has been checked
using the Procheck program (26). The geometry of the final model
complies with statistical criteria. About 98% of the residues fall in
allowed regions (86.2% and 11.5% of phi/psi angles are, respectively, in
the most favored or additional allowed regions) of the Ramachandran
plot, and all bond lengths and valence angles corresponded to expected
values. Graphical outputs were generated with Molscript (27). All cal-
culations were carried out on an O2 SGI workstation operated with Irix
6.2. The coordinates of the model are available upon request to the
authors.
Gel Filtration on the Superdex 200 Column
The gel filtration procedure was carried out at 4 °C. A Superdex 200
column (1.6  60 cm, Amersham Biosciences) was equilibrated with 50
mM Tris-HCl buffer, pH 8.0, containing either 15 mM ornithine or a
concentration stated in the legends of Figs. 2 and 3C, and 1 mM agma-
tine. This column was pre-calibrated with serum albumin (molecular
mass, 66 kDa), E. coli OTCase (molecular mass, 120 kDa), Enterococcus
FIG. 1. Amino acid alignment of
OTCase sequences from different or-
ganisms. OTCase sequence from P. aeru-
ginosa refers to the sequence of the cata-
bolic enzyme. Conserved amino acid
residues are boxed. The position of the
first and last residues is indicated. The
carbamoyl phosphate and ornithine bind-
ing residues in the E. coli enzyme (34) are
indicated in white and boxed in black. The
mutated residues in yeast OTCase are
also in white and boxed in black.  repre-
sents the deletion of the residues covered
by the bracket.
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faecalis OTCase (molecular mass, 240 kDa), and P. furiosus OTCase
(molecular mass, 420 kDa). Elution was carried out with the same
buffer, at a flow rate of 0.5 ml/min, and 0.56-ml fractions were collected.
Activities of OTCase and arginase were determined in each fraction as
described.
DNA Manipulation and DNA Sequencing
Restriction reactions were performed as recommended by the enzyme
supplier. Plasmid DNA was prepared using the alkaline lysis method
(28). Double-stranded DNA was prepared using Qiagen columns. DNA
was sequenced by the Thermosequenase radiolabeled terminator cycle
sequencing kit (Amersham Biosciences). Site-directed in vitro mutagen-
esis was performed with the QuikChange site-directed mutagenesis kit
from Stratagene.
RESULTS
Selection of a Mutated OTCase Resistant to Inhibition by
Arginase Using the Reverse Two-hybrid Assay—As a first at-
tempt to select mutations in OTCase that impair its association
with arginase, we took advantage of assays that had been
developed in yeast (13, 29). We first tested whether OTCase
and arginase do interact in vivo using the two-hybrid assay
(29). Therefore, we fused OTCase and arginase coding se-
quences to the DNA binding domain (GBD) and the activation
domain (GAD) of the Gal4 protein, leading to the chimeric
proteins GBD-OTCase, GAD-OTCase, GBD-arginase, and
GAD-arginase (see “Experimental Procedures”), which were
tested in vivo by the two-hybrid assay. The results indicated a
significant interaction between GBD-OTCase and GAD-argin-
ase and a stronger interaction between GBD-arginase and
GAD-OTCase (data not shown). We used the reverse two-hy-
brid assay to select mutants impaired in the interaction be-
tween the two proteins (see “Experimental Procedures”). The
plasmids of strains growing on 5-fluoroorotic acid were ex-
tracted, purified, and used to transform yeast strain 12S16c for
OTCase activity determination, and strain HY (containing
plasmid GBD-CAR1) was used to confirm the loss of interaction
of these mutated OTCases with arginase. Only one candidate,
named M3, retained sufficient OTCase activity to sustain the
growth of a strain deleted of the ARG3 gene. This residual
OTCase activity was resistant to the inhibition by arginase,
even at ornithine concentrations higher than 100 mM (data not
shown). The GAD-arg3-M3 gene was sequenced and found to
harbor a single replacement Asn for Asp at position 182, a
highly conserved residue present in all OTCases (Fig. 1). The
mutation was introduced in the ARG3 gene yielding plasmid
pFV48 (pGAL10-arg3D182N, 2, URA3). The substitution re-
TABLE I
Characteristics of the mutated OTCases
OTCase activity was assayed at 30 °C in extracts from strain 02859darg3-car1 (ura3, leu2, trp1, arg3::kanMX4, car1) transformed with pYeF2
plasmid containing wild type ARG3 gene or the mutated arg3 genes after growth at 30 °C on M.am plus 2% galactose plus 25 g of leucine plus
g of tryptophan plus 25 g of arginine. The assays were performed in 50 mM Tris-HCl buffer, pH 8, and in the presence of 5 mM CP. The ornithine
concentration used in the inhibition tests varied from 15 mM up to 2-fold the concentration of the apparent Km of mutated OTCases for ornithine.
At least three independent transformants were tested, and the standard error was typically 10-15% of the mean. The OTCase specific activity is
expressed in micromoles of citrulline formed/h/mg of protein.
Plasmids Nature of the mutationin OTCase
OTCase specific activity
measured at saturation
of ornithine and CP
Apparent Km for
ornithine
Remaining activity of
OTCase after inhibition by
500 units of WT arginase
mM %
pDC2 WT 1570 1.6 14
pME223 T68G 77 3.4 18
pME204 E123S 1390 2.1 16
pME206 E123A 1520 2.6 15
pME216 G181R 0 NDa NDa
pFV48 D182N 970 49 100b
pME234 N184Q 740 34 95
pME235 N185Q 1500 350 100
pME211 C191M-C194N-F197V 250 2.8 18
pME205 E256Q 760 1.2 15
pME207 E256A 900 10 94b
pME217 K260R 1510 1.2 16
pME218 K260A 1550 1 16c
pME213 K263R 890 20 100
pME208 K263A 450 30 98
pME240 K265R 1418 1.1 18
pME219 K265A 1010 1.2 47b
pME241 K268R 1544 1.1 18
pME220 K268A 1500 0.05 5d
pME237 C289S 170 10 100
pME238 L290S 280 2 48b
pME239 L290Q 800 2 22
pME221 Q294P 1460 1.3 17
a ND, not detectable. Interaction with arginase in molecular sieving experiment (data not shown).
b Interaction with arginase is absent or reduced in the molecular sieving experiment.
c See Fig. 5B.
d See Fig. 5D.
FIG. 2. In vitro inhibition of wild type OTCase and mutated
OTCase-D182N by wild type arginase. The inhibition test was per-
formed at 30 °C in the presence of 50 mM Tris-HCl, pH 8.0, 15 mM
ornithine for the wild type OTCase and 200 mM for the D182N variant,
1 mM agmatine, and increasing amounts of arginase (4). Maximum
OTCase activity measured in the absence of arginase was taken as
100%. Open circles, WT OTCase; filled squares, OTCase-D182N.
Residues for OTCase-Arginase Interaction and Activity Control 21553
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sulted in a slight reduction of OTCase specific activity, a strong
decrease of the apparent affinity of the mutant enzyme for
ornithine and a total loss of inhibition of its activity by argin-
ase, even at high ornithine concentration (200 mM instead of 15
mM) (Table I and Fig. 2). Moreover, OTCase-D182N had lost
the capacity to interact with arginase, as shown by molecular
sieving (Fig. 3). In the presence of ornithine and arginine, wild
type OTCase and arginase formed a complex of about 200 kDa,
whereas, in contrast, OTCase-D182N and wild type arginase
were unable to form such a complex, even at a concentration of
ornithine equivalent to 2-fold the apparent Km value (Fig. 3
and Table I).
Construction of Additional Mutations in OTCase by in Vitro
Mutagenesis—At present more than 60 OTCase amino acid
sequences are available (SwissProt search, 2002), and the crys-
tal structure of OTCases from P. aeruginosa, E. coli, P. furio-
sus, and human are known (30–33). Each polypeptide chain
from these trimeric enzymes folds into two domains, a carbam-
oyl phosphate binding domain and an L-ornithine binding do-
main (Fig. 4A). As shown in Fig. 1, alignment of the amino acid
sequences of these OTCases and those of S. cerevisiae and
S. pombe shows large regions of identity but also reveals sev-
eral regions where the sequences diverge significantly. The
region from residue 161 to 168 in particular is unique to the
S. cerevisiae OTCase. However, deletion of amino acids E166/
V167/N168/K169 ( in Fig. 1) had no effect on the OTCase-
arginase interaction (data not shown). Surprisingly, the muta-
tion D182N rendering OTCase insensitive to arginase occurs in
a conserved stretch (Gly-181, Asp-182, Asn-184, and Asn-185)
in which some amino acids might interact with ornithine, ac-
FIG. 3. Elution profile of a mixture of arginase and OTCase
extracted from wild type and mutant strains. The molecular mass
of arginase is about 114 kDa and that of OTCase is about 120 kDa (A).
When the two enzymes are associated as in B, the molecular mass of the
associated peak is about 200 kDa. Arginase and OTCase from wild type
and mutant strains were eluted on Superdex 200 column with Tris-HCl
50 mM, pH 8.0. A, elution profile of 2400 units of WT OTCase (open
circles) and 1000 units of WT arginase (filled circles), in the absence of
ornithine and agmatine. B, elution profile of a mixture of 3400 units of
WT OTCase (open circles) and 900 units of WT arginase (filled circles),
in the presence of 15 mM ornithine and 1 mM agmatine. C, elution
profile of a mixture of 400 units of mutant OTCase D182N (open circles)
and 500 units of WT arginase (filled circles), in the presence of 200 mM
ornithine and 1 mM agmatine.
FIG. 4. View of the -carbon chain of the predicted structure of
the OTCase monomer from S. cerevisiae using the structure of
the E. coli OTCase as template. A, E. coli OTCase monomer taken
from the crystal structure reported by Ha et al. (34). Residues interact-
ing with ornithine are indicated. Secondary structure elements:  hel-
ices are represented by cylinders, and  strands are represented by
arrows. B, S. cerevisiae OTCase monomer modeled on the basis of the
structure of E. coli OTCase. Residues required for regulation by argin-
ase are indicated. C, S. cerevisiae OTCase monomer. Residues whose
changes did not affect the OTCase-arginase interaction are indicated.
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cording to studies on E. coli OTCase complexed with the bisub-
strate analog N-(phosphoacetyl)-L-ornithine (PALO) (34). Fig.
4A represents a monomer of E. coli OTCase, with the CP
binding domain on the left and the ornithine binding domain on
the right, and with L-ornithine binding to residues Asp-163,
Asn-166, Asn-167, Glu-238, Cys-273, and Leu-274 (indicated in
the E. coli sequence of Fig. 1, according to the data of Ref. 34).
Among the crystal structures of OTCases available in the lit-
erature, the structure of E. coli (PDB code 1a1s) was retained
to construct a model of yeast OTCase by homology modeling
(Fig. 4, B and C, see “Experimental Procedures”). According to
this model, Asp-182 in yeast OTCase could interact with resi-
dues of the SMG loop (Ser-253, Met-254, and Gly-255) involved
in the closure of the ornithine and carbamoyl phosphate do-
mains in the presence of the substrates. We chose to modify a
series of residues in the vicinity of Asp-182, within and around
the SMG loop, in the CP binding site, and in the ornithine
binding site. The following substitutions were introduced:
T68G, E123S, E123A, G181R, N184Q, N185Q, C191M/C194N/
F197V, E256Q or E256A, K260R or K260A, K263R or K263A,
K265R or K265A, K268R or K268A, C289S, L290S or L290Q,
and Q294P (see “Experimental Procedures”). These residues
are marked in the S. cerevisiae OTCase sequence in Fig. 1
(white residues boxed in black). Residue Thr-68 is located in the
STRTR sequence known to be involved in the binding of CP in
E. coli OTCase, whereas Asn-184, Asn-185, Glu-256, Cys-289,
and Leu-290 are in yeast OTCase residues that are liable to
bind ornithine, in addition to Asp-182. Residue Glu-123 is
located in the CP binding domain but opposite to the SMG loop
and could therefore make contact with residues in this loop.
The data presented in Table I show the specific activities of the
mutated OTCases determined at saturation for both sub-
strates, their apparent Km for ornithine, and their sensitivity to
arginase, determined as in Fig. 2. In none of the mutated
OTCases was the apparent Km for CP significantly modified,
except for the protein bearing the T68G substitution, which
increased the apparent Km for CP from 0.1 to 2.4 mM. According
to Western blot analysis, the amounts of the mutated OTCases
were comparable to those of the wild type OTCase, indicating
that the decrease in enzyme specific activities did not result
from a lack of protein stability or reduced enzyme production
(data not shown). Moreover, molecular sieving experiments
showed that the mutations did not affect the trimeric structure
of the different OTCases (data not shown).
The mutants fell into several categories. Some mutations did
not affect any of the enzyme properties: E123S or E123A,
K260R, and Q294P. The simultaneous replacements of Cys-
191, Cys-194, and Phe-197 by the corresponding residues pres-
ent in the S. pombe OTCase (MNV) reduced the enzyme activ-
ity, as did the T68G substitution. However, these two
mutations did not modify the sensitivity of the enzyme to
arginase (Table I). The replacement G181R completely abol-
ished the enzyme activity but did not compromise its interac-
tion with arginase, a 200-kDa complex being formed with wild
type OTCase (data not shown).
In contrast, the substitutions N184Q, N185Q, E256A,
K263R, K263A, and C289S led to an important modification of
the affinity of the mutant OTCases for ornithine: the specific
activities in crude cell extracts were reduced, and the enzymes
were insensitive to arginase inhibition, even at high ornithine
FIG. 5. Inhibition of wild type and mutated OTCases (K260A, K265A, K268A) by wild type arginase as a function of ornithine
concentration. The velocity of the reaction catalyzed by wild type and mutated OTCases was measured at 30 °C in 50 mM Tris-HCl buffer, pH
8.0, in the presence of 5 mM CP, 1 mM agmatine, different concentrations of ornithine, and in the presence or absence of wild type arginase. The
maximum OTCase activity measured in the absence of arginase was taken as 100%. A, wild type OTCase in the absence of arginase (open circles),
in the presence of 200 units of arginase (filled circles), and in the presence of 500 units of arginase (filled triangles). B, OTCase-K260A in the
absence of arginase (open circles), in the presence of 200 units of arginase (filled circles), and in the presence of 500 units of arginase (filled
triangles). C, OTCase-K265A in the absence of arginase (open circles), in the presence of 200 units of arginase (filled circles), and in the presence
of 500 units of arginase (filled triangles). D, OTCase-K268A in the absence of arginase (open circles) and in the presence of 200 units of arginase
(filled circles). Note the change of scale in this figure compared with Fig. 5 (A–C).
Residues for OTCase-Arginase Interaction and Activity Control 21555
 at B
IB
LIO
TH
EQUE UNIV DE NAM
UR on M
ay 14, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
concentration (up to 10-fold the apparent Km value). The effects
were comparable to those observed for the D182N mutation
selected in vivo. The E256A substitution caused a reduction of
the apparent affinity of the enzyme for ornithine and impaired
its interaction with arginase, whereas the E256Q substitution
only reduced the specific activity of the enzyme. The K260A,
but not K260R, replacement had no effect on the interaction of
OTCase with arginase when the test was performed with 15
mM ornithine, but the interaction was reduced at lower orni-
thine concentrations, as shown in Fig. 5B (compared with Fig.
5A with wild type OTCase). In contrast to the mutations de-
scribed above, the substitution K268A, but not K268R, resulted
in an enhanced affinity of the enzyme for ornithine. The
OTCase-K268A was extremely sensitive to inhibition by excess
of ornithine as compared with the wild type enzyme and exhib-
ited a higher sensitivity to arginase as shown in Fig. 5D.
Interestingly, the two mutations K265A (Fig. 5C) and L290S
rendered the OTCase less sensitive to arginase without affect-
ing the apparent Km of the mutated enzymes for ornithine. The
substitution L290S was not expected to affect the catalytic
properties of yeast OTCase, because its main chain only is
involved in the direct stabilization of CP and ornithine (33),
whereas the side chain of leucine is probably involved in inhi-
bition by arginase. As indicated in Table I, most of the mutated
OTCases had lost the capacity to interact with wild type arginase
in molecular sieving experiments. Moreover, for some mutated
enzymes, D182N, E256A, and K265A, the reduction of inhibition
by arginase was correlated with the loss of interaction between
the two proteins using the two-hybrid assay (data not shown).
Fig. 4B shows those amino acids that appear to be important for
the association of OTCase with arginase, whereas Fig. 4C shows
those residues that were found not to be involved.
Construction of Mutations in Arginase by in Vitro Mutagen-
esis—The comparison of the available arginase amino acid
sequences (S. cerevisiae, S. pombe, Rattus norvegicus, and Ba-
cillus caldovelox) revealed the presence in the S. cerevisiae
enzyme of several short sequences that are absent or different
in the arginases devoid of regulatory properties (Fig. 6). Among
the known arginase sequences, R. norvegicus and B. caldovelox
arginases were chosen for this comparison because their crystal
structures had been determined (35, 36). Regions of interest in
the S. cerevisiae arginase were those between amino acids 78
and 86 (indicated by the arrow in Fig. 6), and more interest-
ingly, the C-terminal end of the enzyme, which contains several
cysteine and histidine residues that could constitute a zinc
finger-like element (white residues in black boxes). The group of
P. Hensley (37) has demonstrated that the binding of a weakly
bound Mn2 ion confers catalytic activity, whereas the binding
of a more tightly associated Zn2 ion confers substantial sta-
bility to the tertiary and quaternary structure of the enzyme,
thus possibly playing a role in the formation of the OTCase-
arginase multienzyme complex. As a first attempt to localize in
the arginase residues involved in its interaction with OTCase,
we generated four mutants. The deletion of amino acids 78–86
(pAM4) and the replacements of H309K/H312E (pME209),
C321R/C326T (pME210), and H309K/H312E/C321R/C326T
(pME222) in the C-terminal end of arginase were constructed
by in vitro mutagenesis in plasmid pEJ24 expressing the CAR1
gene under the GAL10 promoter, as described under “Experi-
mental Procedures.” It must be emphasized that the amino acid
replacements mentioned above introduce the cognate residues
present in S. pombe arginase. The plasmids obtained were used
to transform yeast strain 02859darg3-car1 (arg3::kanMX4,
car1, leu2, trp1, ura3) on M.am-glucose supplemented with 25
g of arginine, 25 g of leucine, and 25 g of tryptophan, per
milliliter. Arginase specific activities were measured in the
transformants bearing either the wild type or the mutated
CAR1 genes, after growth on M.am-galactose supplemented
with 25 g of arginine, 25 g of leucine, and 25 g of trypto-
phan, per milliliter. Deletion of the 9-amino acid stretch (78–
86) unique to the S. cerevisiae arginase had no effect on argi-
nase activity and did not modify its inhibitory capacity on
OTCase activity (data not shown). Replacing the two cysteines
completely abolished the regulatory function of arginase, which
had lost the capacity to bind and inhibit OTCase. In contrast,
the substitution of the two histidine residues had only a minor
effect (Table II and Fig. 7A). These mutations did not alter
significantly the enzymatic properties of the enzymes; their
catalytic activity and their affinity for arginine were unaffected
(Table II). Moreover, the simultaneous substitution of the two
cysteines and the two histidines only led to a 50% reduction of
the activity without affecting the Km of the enzyme for argi-
nine. Such a reduction could result from a slight effect on
enzyme stability. The loss of interaction between the arginase-
C231R-C326T and the wild type OTCase was confirmed using
the two-hybrid assay (data not shown) and by molecular siev-
ing (Fig. 7, B and C). Addition of mercaptoethanol in the inhi-
bition test (data not shown) did not affect the regulatory capac-
ity of wild type arginase. Moreover, addition of 1 mM zinc
acetate in the molecular sieving experiment performed with
wild type OTCase and arginase-C321R-C326T did not restore
the formation of an OTCase-arginase complex (data not
shown). As shown in Fig. 7C, the molecular mass of the mu-
tated arginase was comparable to that of the wild type enzyme
(about 114 kDa, shown in Fig. 3), indicating that the mutated
enzyme was still a trimer. The two cysteine residues are thus
important for the epiarginase function, whereas the binding of
FIG. 6. Amino acid alignment of arginase sequences from dif-
ferent organisms. Conserved amino acid residues are boxed. The
positions of the first and last residues are indicated. The histidine and
cysteine residues are indicated by white letters in black boxes. “”
represents the deletion of the residues covered by the bracket.
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zinc to the enzyme, although necessary to maintain its quater-
nary structure (37), does not require the two cysteines. The
arginase from Pichia sorbitophila (sequence provided by the
Genolevures project) (38), which contains the two cysteines, is
unable to inhibit S. cerevisiae OTCase (data not shown). Cys-
321 and Cys-326 are thus necessary but not sufficient to confer
a regulatory function to arginase.
DISCUSSION
For the yeast OTCase, as for most of OTCases, the catalysis
of carbamoylation was predicted to follow a preferred ordered
Bi-Bi binding mechanism with carbamoyl phosphate (CP) being
the first substrate bound and ornithine the second one (enzyme-
CP-ornithine) (39, 40). In such a kinetic mechanism, a high
ornithine concentration could favor a slower pathway of central
ternary complex formation (enzyme-ornithine-CP) leading to in-
hibition of OTCase activity. In agreement with such a mecha-
nism, it was shown that increasing the concentration of the
preferred substrate (CP) overcame the inhibition of OTCase by
ornithine and reduced its inhibition by arginase (4). Ornithine
binding to the free enzyme could promote a conformational
change in the enzyme, which could potentiate its association with
arginase. The crucial role of ornithine in this regulatory process
is emphasized by the fact that carbamoyl phosphate cannot re-
place ornithine in the complex with arginase,2 and mutating
Thr-68 to Gly in the STRTR carbamoyl phosphate binding do-
main, which had a dramatic effect on the catalytic activity of the
enzyme, had no effect on its interaction with arginase (Table I).
By mutation analysis we identified in S. cerevisiae OTCase
two regions required for the OTCase-arginase interaction. Res-
idues Asp-182, Asn-184, Asn-185, Cys-289, and Leu-290 are
crucial for the regulation by arginase and are probably involved
in the binding of ornithine, based on the structure of the E. coli
OTCase bound to the bisubstrate analog PALO (33, 34). In the
E. coli enzyme, Asp-231, Ser-235, and Met-236 are part of the
flexible SMG loop, the main binding site for ornithine. In yeast
OTCase, Glu-256 located in the SMG loop could also participate
in ornithine binding, because its replacement strongly reduced
the apparent affinity of OTCase for ornithine to the same
extent as the replacement of residues Asp-182, Asn-184, Asn-
185, and Cys-289. In contrast, the four lysine residues, Lys-
260, Lys-263, Lys-265, and Lys-268 in the SMG loop were not
reported to bind PALO in E. coli and human OTCases but
appear to play an important role in the interaction between
OTCase and arginase. Changing Lys-260, Lys-265, or Lys-268
to arginine had no effect, but their replacement by alanine
modified the interaction with arginase attesting the impor-
tance of a basic residue at those positions. OTCase-K260A was
only slightly less sensitive to arginase at low ornithine concen-
tration, whereas OTCase-K265A had lost 50% of the inhibition
capacity, but exhibited a normal Km for ornithine. In contrast,
OTCase-K268A had a better affinity for ornithine than the wild
type enzyme and, consequently, was much more sensitive to
arginase at an ornithine concentration below 1 mM. Residue
Lys-263 is of particular interest. When mutated to arginine,
2 M. El Alami, E. Dubois, Y. Oudjama, C. Tricot, J. Wouters, V.
Stalon, and F. Messenguy, unpublished results.
TABLE II
Characteristics of the mutated arginases
Arginase activity was assayed in 30 °C in extracts from strain 02859darg3-car1 (ura3, leu2, trp1, arg3::kanMX4, car1) transformed with
pYeF2 plasmid containing wild type car1 gene or the mutated car1 genes after growth at 30 °C on M.am plus 2% galactose plus 25 g of leucine
plus 25 g of tryptophan plus 25 g of arginine. At least three independent transformants were tested and the standard error was typically 10-15%
of the mean. The arginase specific activity is expressed in Micromoles of urea formed/h/mg of protein.
Plasmids Nature of the mutation inarginase
Arginase specific
activity Km for arginine
Remaining activity of WT
OTCase after inhibition
by 500 units of arginase
mM %
pEJ24 WT 6000 6.5 14
pME209 H309K-H312E 5800 6.9 16
pME210 C321R-C326T 4700 7.1 91
pME222 H309K-H312E-C321R-C326T 3000 6.7 90
FIG. 7. In vitro inhibition of wild type OTCase by wild type and
mutated arginases and elution profiles of a mixture of wild type
OTCase and mutated arginases. A, the inhibition test was per-
formed at 30 °C in the presence of 50 mM Tris-HCl, pH 8.0, 15 mM
ornithine, and 1 mM agmatine. Wild type arginase (filled circles), argi-
nase-H309K, H312E (filled squares), arginase-C321R, C326T (filled
triangles), and arginase-H309K, H312E, C321R, C326T (open trian-
gles). B, elution profile of a mixture of 3200 units of wild type OTCase
(open circles) with 900 units of mutated arginase-H309K, H312E (filled
circles) in the presence of 15 mM ornithine and 1 mM agmatine. C,
elution profile of a mixture of 3200 units of WT OTCase (open circles)
and 2500 units of mutated arginase-C321R, C326T (filled circles), in the
presence of 15 mM ornithine and 1 mM agmatine.
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the amino acid present at that position in many other OTCases,
the apparent Km of the yeast enzyme for ornithine dropped
about 15-fold, rendering OTCase-K263R insensitive to argin-
ase. Thus Lys-263 may constitute one of the key residues that
differentiates S. cerevisiae OTCase from other OTCases for its
inhibition by arginase. The four lysines, Lys-260, Lys-263, Lys-
265, and Lys-268, appear to constitute contact points with
arginase, when the latter enzyme binds arginine or agmatine,
inducing a modification of the catalytic site conformation and
reducing the catalytic activity of OTCase. In E. coli OTCase,
the SMG loop undergoes a large conformational change upon
substrate binding. It is possible that the yeast enzyme under-
goes the transition from the open to the closed states with more
ease than other OTCases and that the binding of arginase
enhances this effect. Lysine 268 seems to restrain the transi-
tion, because K268A substitution results in an improved affin-
ity for ornithine and an enhanced sensitivity to excess orni-
thine and to inhibition by arginase. Whether ornithine acts
directly on these lysine residues remains questionable, but
they could be involved in transducing and enhancing the signal
given by ornithine for catalytic domain closure.
The regulatory function of arginase requires at least the
residues Cys-321 and Cys-326. The group of Hensley (37) had
proposed that these two cysteines form a putative “Zinc finger-
like” element with the residues His-309 and His-312 and that
this structure could be involved in stabilizing subunit interac-
tions and, thus, play a role in the formation of the OTCase-
arginase complex. However, modifying these four residues had
no strong effect on the catalytic activity of arginase and did not
modify the trimeric structure of the enzyme, suggesting that
these amino acids are not crucial for the zinc-dependent en-
zyme stability. Moreover, few known arginases contain the two
histidine and cysteine residues in their C-terminal end. Our data
demonstrate that the two cysteine residues are necessary for the
epiarginase function of the yeast arginase but that they are not
sufficient, because the arginase from P. sorbitophila containing
these two amino acids has no regulatory capacity. Based on
sequence alignments and on crystal structures, no suitable tem-
plates are available to model the C-terminal part of the protein.
It is worth noting that the S. cerevisiae arginase contains two
arginine binding sites (41) that might not be present in arginases
of other species. Thus, determining the crystal structure of this
unusual arginase and of the OTCase-arginase complex, with and
without their effectors, will help to unravel this intricate mech-
anism of enzyme regulation by protein-protein association.
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